This study is aimed to evaluate expression and transcription correlations between MGMT and already clinically relevant cell cycle regulators involved in breast cancer oncogenesis, chemotherapy resistance (TOP2A for anthracyclines, KIF20A for taxol) [25, 26, 33] and hormonal therapy resistance (ARUKB) [31]. Here, MGMT is linked to breast cancer.